Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome

Martin Zenker et al. J Med Genet. 2007 Oct.

Abstract

Background: Heterozygous gain-of-function mutations in various genes encoding proteins of the Ras-MAPK signalling cascade have been identified as the genetic basis of Noonan syndrome (NS) and cardio-facio-cutaneous syndrome (CFCS). Mutations of SOS1, the gene encoding a guanine nucleotide exchange factor for Ras, have been the most recent discoveries in patients with NS, but this gene has not been studied in patients with CFCS.

Methods and results: We investigated SOS1 in a large cohort of patients with disorders of the NS-CFCS spectrum, who had previously tested negative for mutations in PTPN11, KRAS, BRAF, MEK1 and MEK2. Missense mutations of SOS1 were discovered in 28% of patients with NS. In contrast, none of the patients classified as having CFCS was found to carry a pathogenic sequence change in this gene.

Conclusion: We have confirmed SOS1 as the second major gene for NS. Patients carrying mutations in this gene have a distinctive phenotype with frequent ectodermal anomalies such as keratosis pilaris and curly hair. However, the clinical picture associated with SOS1 mutations is different from that of CFCS. These findings corroborate that, despite being caused by gain-of-function mutations in molecules belonging to the same pathway, NS and CFCS scarcely overlap genotypically.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Tartaglia M, Mehler E L, Goldberg R, Zampino G, Brunner H G, Kremer H, van der Burgt I, Crosby A H, Ion A, Jeffery S, Kalidas K, Patton M A, Kucherlapati R S, Gelb B D. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP‐2, cause Noonan syndrome. Nat Genet 200129465–468. - PubMed
    1. Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, Filocamo M, Kato K, Suzuki Y, Kure S, Matsubara Y. Germline mutations in HRAS proto‐oncogene cause Costello syndrome. Nat Genet 2005371038–1040. - PubMed
    1. Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, Verloes A, Okamoto N, Hennekam R C, Gillessen‐Kaesbach G, Wieczorek D, Kavamura M I, Kurosawa K, Ohashi H, Wilson L, Heron D, Bonneau D, Corona G, Kaname T, Naritomi K, Baumann C, Matsumoto N, Kato K, Kure S, Matsubara Y. Germline KRAS and BRAF mutations in cardio‐facio‐cutaneous syndrome. Nat Genet 200638294–296. - PubMed
    1. Rodriguez‐Viciana P, Tetsu O, Tidyman W E, Estep A L, Conger B A, Cruz M S, McCormick F, Rauen K A. Germline mutations in genes within the MAPK pathway cause cardio‐facio‐cutaneous syndrome. Science 20063111287–1290. - PubMed
    1. Schubbert S, Zenker M, Rowe S L, Boll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner L E, Nguyen H, West B, Zhang K Y, Sistermans E, Rauch A, Niemeyer C M, Shannon K, Kratz C P. Germline KRAS mutations cause Noonan syndrome. Nat Genet 200638331–336. - PubMed

Publication types

Substances